Gain Therapeutics announces Phase 1b clinical trial approval in Australia for GT-02287 to evaluate safety in Parkinson's disease patients. Gain Therapeutics, Inc. has received approval to start ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results